New FDA-Cleared SensititreÃ‚® AIMâ„¢ Automated Inoculation Delivery System Provides Faster, Accurate Dosing of MIC Plates for Microbiology Laboratories
CLEVELAND, July 12, 2011 /PRNewswire/ -- Magellan Biosciences, a global manufacturer of products designed to make diagnostic testing easier, more cost-effective, and less labor intensive, announced the FDA clearance of its new TREK Diagnostic Systems-brand Sensititre AIM Automated Inoculation Delivery System for use with all Sensititre dried plates. The small-footprint Sensititre AIM System quickly and accurately doses microtitre plates, eliminating both skipped wells and costly repeat tests, to improve laboratory workflow and speed results to busy clinicians.
The Sensititre AIM System's compact, user-friendly design is ideal for use directly on the benchtop or under a microbiology safety cabinet, providing flexible storage and accessibility and conserving valuable laboratory space. The easy-to-use, icon-driven touch screen facilitates quick selection of dosing volumes and patterns for simple, intuitive operation.
According to Magellan President and Chief Executive Officer Hiroshi Uchida, Ph.D., "The goal of the new Sensititre AIM System and all of our IVD susceptibility products is to make it easier for clinicians to accurately determine the right combination of antimicrobics to fight infection and the emerging problem of drug resistance. Over the past two years, we have extended our portfolio of FDA-cleared products, including the latest FDA-cleared antimicrobics to provide a unique system that improves workflow and reduces costs.
"Systems that perform accurately while providing faster results are an obvious choice for busy laboratorians, but limited space for new instrumentation is a major concern. With the new Sensititre AIM System, laboratorians can conserve benchtop space and enhance workflow without sacrificing the accuracy they demand in plate inoculation," Dr. Uchida continued.
The AIM System has been used successfully in veterinary and pharmaceutica